Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-28.62%
operating margin TTM
-38.97%
revenue TTM
41.85 Million
revenue per share TTM
0.67$
valuation ratios | |
|---|---|
| pe ratio | -3.95 |
| peg ratio | -0.04 |
| price to book ratio | 4.64 |
| price to sales ratio | 1.13 |
| enterprise value multiple | -1.23 |
| price fair value | 4.64 |
profitability ratios | |
|---|---|
| gross profit margin | 78.65% |
| operating profit margin | -38.97% |
| pretax profit margin | -34.28% |
| net profit margin | -28.62% |
| return on assets | -23.14% |
| return on equity | -91.54% |
| return on capital employed | -40.43% |
liquidity ratios | |
|---|---|
| current ratio | 2.11 |
| quick ratio | 1.71 |
| cash ratio | 0.75 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 185.05 |
| operating cycle | 258.35 |
| days of payables outstanding | 140.34 |
| cash conversion cycle | 118.02 |
| receivables turnover | 4.98 |
| payables turnover | 2.60 |
| inventory turnover | 1.97 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.59 |
| debt equity ratio | 3.01 |
| long term debt to capitalization | 0.75 |
| total debt to capitalization | 0.75 |
| interest coverage | -5.79 |
| cash flow to debt ratio | -0.36 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.16 |
| cash per share | 0.12 |
| operating cash flow per share | -0.16 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.36 |
| short term coverage ratios | -19.10 |
| capital expenditure coverage ratio | -43.91 |
Frequently Asked Questions
When was the last time Cytosorbents Corporation (NASDAQ:CTSO) reported earnings?
Cytosorbents Corporation (CTSO) published its most recent earnings results on 13-11-2025.
What is Cytosorbents Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cytosorbents Corporation (NASDAQ:CTSO)'s trailing twelve months ROE is -91.54%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cytosorbents Corporation (CTSO) currently has a ROA of -23.14%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CTSO's net profit margin stand at?
CTSO reported a profit margin of -28.62% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CTSO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.11 in the most recent quarter. The quick ratio stood at 1.71, with a Debt/Eq ratio of 3.01.